Botulinum A toxin for treatment of lower limb spasticity in cerebral palsy: Gait analysis in 49 patients

Acta Orthopaedica Scandinavica

Volumn 74, Issue 6, 2003, Pages 749-755

  Papadonikolakis, Anastasios S ^a   Vekris, Marios D ^a   Korompilias, Anastasios V ^a   Kostas, John P ^a   Ristanis, Stavros E ^a   Soucacos, Panayotis N ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ADOLESCENT; ADULT; ANKLE; ARTICLE; CEREBRAL PALSY; CHILD; CLINICAL ARTICLE; COMPUTER ANALYSIS; CONTROLLED STUDY; DRUG EFFECT; DRUG RESPONSE; DRUG SCREENING; ECHOGRAPHY; EVALUATION; FUNCTIONAL ASSESSMENT; GAIT; GASTROCNEMIUS MUSCLE; HAMSTRING; HEALTH; HUMAN; INJECTION; JOINT MOBILITY; KNEE; LEG; LEG MUSCLE; MEASUREMENT; MOTOR PERFORMANCE; PATIENT; QUESTIONNAIRE; SPASTICITY; THREE DIMENSIONAL IMAGING; VELOCITY;

ADOLESCENT; ADULT; BOTULINUM TOXIN TYPE A; CEREBRAL PALSY; CHILD; CHILD, PRESCHOOL; GAIT; HUMANS; MOTOR SKILLS; MUSCLE SPASTICITY; NEUROMUSCULAR AGENTS; PROSPECTIVE STUDIES;

EID: 0347601712     PISSN: 00016470     EISSN: None     Source Type: Journal    
DOI: 10.1080/00016470310018315     Document Type: Article

References (29)

1. Arens L J, Goldschmidt R B, Leary P M. Botulinum toxin treatment in cerebral palsy: intervention with poor evaluation? Dev Med Child Neurol 1998; 40 (11): 785-7.
2. Bemben M G. Use of diagnostic ultrasound for assessing muscle size. J Strength Cond Res 2002; 16 (1): 103-8.
3. Boyd R N, Britton T C, Robinson R O, Borzyskowski M. Transient urinary incontinence after botulinum A toxin. Lancet 1996; 348 (9025): 481-2.
4. Boyd R N, Pliatsios V, Starr R, Wolfe R, Graham H K. Biomechanical transformation of the gastrocnemius-soleus muscle with botulinum toxin A in children with cerebral palsy. Dev Med Child Neurol 2000; 42 (1): 32-41.
5. Chambers H, Lauer A, Kaufman K, Cardelia J M, Sutherland D. Prediction of outcome after rectus femoris surgery in cerebral palsy: the role of cocontraction of the rectus femoris and vastus lateralis. J Pediatr Orthop 1998; 18 (6): 703-11.
6. Corry I S, Cosgrove A P, Duffy C M, McNeill S, Taylor T C, Graham H K. Botulinum toxin A compared with stretching casts in the treatment of spastic equinus: a randomised prospective trial. J Pediatr Orthop 1998; 18 (3): 304-11.
7. Corry I S, Cosgrove A P, Duffy C M, Taylor T C, Graham H K. Botulinum toxin A in hamstring spasticity. Gait Posture 1999; 10 (3): 206-10.
8. Cosgrove A P, Corry I S, Graham H K. Botulinum toxin in the management of the lower limb in cerebral palsy. Dev Med Child Neurol 1994; 36 (5): 386-96.
9. DeLuca P A, Ounpuu S, Davis R B, Walsh J H. Effect of hamstring and psoas lengthening on pelvic tilt in patients with spastic diplegic cerebral palsy. J Pediatr Orthop 1998; 18 (6): 712-8.
10. Eames N W, Baker R, Hill N, Graham K, Taylor T, Cosgrove A. The effect of botulinum toxin A on gastrocnemius length: magnitude and duration of response. Dev Med Child Neurol 1999; 41 (4): 226-32.
11. Gage J R, DeLuca P A, Renshaw T S. Gait analysis: principle and applications with emphasis on its use in cerebral palsy. Instr Course Lect 1996; 45 (10): 491-507.
12. Goldberg M J. Botulinum toxin type A improved ankle function in children with cerebral palsy and dynamic equinus foot deformity. J Bone Joint Surg (Am) 2000; 82 (6): 874.
13. Kao I, Drachman D B, Price D L. Botulinum toxin: mechanism of presynaptic blockade. Science 1976; 193 (4259): 1256-8.
14. Koman L A, Mooney J F, III, Smith B, Goodman A, Mulvaney T. Management of cerebral palsy with botulinum-A toxin: preliminary investigation. J Pediatr Orthop 1993; 13 (4): 489-95.
15. Koman L A, Mooney J F, III, Smith B P, Walker F, Leon J M. Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: a randomized, double-blind, placebo-controlled trial. BOTOX Study Group. J Pediatr Orthop 2000; 20 (1): 108-15.
16. Koman L A, Brashear A, Rosenfeld S, et al. Botulinum toxin type A neuromuscular blockade in the treatment of equinus foot deformity in cerebral palsy: a multicenter, open-label clinical trial. Pediatrics 2001; 108 (5): 1062-71.
17. McMulkin M L, Gulliford J J, Williamson R V, Ferguson R L. Correlation of static to dynamic measures of lower extremity range of motion in cerebral palsy and control populations. J Pediatr Orthop 2000; 20 (3): 366-9.
18. Metaxiotis D, Siebel A, Doederlein L. Repeated botulinum toxin A injections in the treatment of spastic equinus foot. Clin Orthop 2002; 394; 177-85.
19. Molenaers G, Desloovere K, De Cat J, et al. Single event multilevel botulinum toxin type A treatment and surgery: similarities and differences. Eur J Neurol (Suppl 5) 2001; 8: 88-97.
20. Novacheck, T F. Assessing Functional Outcomes. 1997. Connecticut Children's Medical Center, Hartford, Connecticut, U.S.A. Clinical Gait Analysis. A Focus on Interpretation. Course Handout April 24, 1997.
21. Novacheck T F, Stout J L, Tervo R. Reliability and validity of the Gillette Functional Assessment Questionnaire as an outcome measure in children with walking disabilities. J Pediatr Orthop 2000; 20 (1): 75-81.
22. Papadonikolakis A S, Vekris M D, Kostas J P, Korompilias A V, Soucacos P N. Transient erectile dysfunction associated with botulinum type A intramuscular injection. J South Orthop Assoc 2002; 11 (2): 116-88.
23. Sampaio C, Ferreira J J, Simoes F, et al. DYSBOT: a single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A -Dysport and Botox - assuming a ratio of 4:1. Mov Disord 1997; 12 (6): 1013-8.
24. Sutherland D H, Kaufman K R, Wyatt M P, Chambers H G, Mubarak S J. Double-blind study of botulinum A toxin injections into the gastrocnemius muscle in patients with cerebral palsy. Gait Posture 1999; 10 (1): 1-9.
25. Thompson N S, Baker R J, Cosgrove A P, Corry I S, Graham H K. Musculoskeletal modelling in determining the effect of botulinum toxin on the hamstrings of patients with crouch gait. Dev Med Child Neurol 1998; 40 (9): 622-5.
26. To E W, Ahuja A T, Ho W S, et al. A prospective study of the effect of botulinum toxin A on masseteric muscle hypertrophy with ultrasonographic and electromyographic measurement. Br J Plast Surg 2001; 54 (3): 197-200.
27. Ubhi T, Bhakta B B, Ives H L, Allgar V, Roussounis S H. Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy. Arch Dis Child 2000; 83 (6): 481-7.
28. Willenborg M J, Shilt J S, Smith B P, Estrada R L, Castle J A, Koman L A. Technique for iliopsoas ultrasound-guided active electromyography-directed botulinum A toxin injection in cerebral palsy. J. Pediatr Orthop 2002; 22 (2): 165-8.
29. Wissel J, Heinen F, Schenkel A, et al. Botulinum toxin A in the management of spastic gait disorders in children and young adults with cerebral palsy: a randomized, double-blind study of "high-dose" versus "low-dose" treatment. Neuropediatrics 1999; 30 (3): 120-4.